Clinical trial
Irinotecan and Cisplatin With or Without Amifostine in Treating Children With…
NCT00004919 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00004919 |
|---|---|
| Title | Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy |
| Official title | A Trial of Irinotecan and Cisplatin in Children With Refractory Solid Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Drug, Other |
| Interventions | cisplatin, irinotecan hydrochloride, amifostine trihydrate, pharmacological study |
| Enrollment | 30 |
| Start date | Dec 1, 1999 |
| Primary completion | Mar 1, 2003 |
| First posted | Feb 12, 2004 |
| Last update posted | Jul 2, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: